Xu T - Search Results

1

KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration.

Wang Z, Wu D, Dong M, Xia Y, Xu T. Wang Z, et al. Among authors: xu t. Transl Cancer Res. 2021 Jan;10(1):261-272. doi: 10.21037/tcr-20-2099. Transl Cancer Res. 2021. PMID: 35116258 Free PMC article.

2

Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis.

Wang Z, Wu D, Xia Y, Yang B, Xu T. Wang Z, et al. Among authors: xu t. Ann Transl Med. 2021 Mar;9(5):379. doi: 10.21037/atm-20-3621. Ann Transl Med. 2021. PMID: 33842600 Free PMC article.

3

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.

Xu T, Dong M, Wang Z, Li H, Li X. Xu T, et al. Cancer Manag Res. 2020 Jul 14;12:5773-5786. doi: 10.2147/CMAR.S253349. eCollection 2020. Cancer Manag Res. 2020. PMID: 32765080 Free PMC article.

4

Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer.

Xu T, Wang Z, Dong M, Wu D, Liao S, Li X. Xu T, et al. Aging (Albany NY). 2020 Sep 11;12(17):17305-17327. doi: 10.18632/aging.103712. Epub 2020 Sep 11. Aging (Albany NY). 2020. PMID: 32915772 Free PMC article.

5

Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis.

Xu T, Liu J, Xia Y, Wang Z, Li X, Gao Q. Xu T, et al. Ann Med. 2021 Dec;53(1):916-928. doi: 10.1080/07853890.2021.1937694. Ann Med. 2021. PMID: 34134578 Free PMC article.

6

S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis.

Wang G, Li HN, Cui XQ, Xu T, Dong ML, Li SY, Li XR. Wang G, et al. Among authors: xu t. J Cancer. 2021 Jul 30;12(19):5760-5771. doi: 10.7150/jca.51855. eCollection 2021. J Cancer. 2021. PMID: 34475990 Free PMC article.

7

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer.

Xu T, Wang Z, Liu J, Wang G, Zhou D, Du Y, Li X, Xia Y, Gao Q. Xu T, et al. Front Oncol. 2022 Jun 8;12:820696. doi: 10.3389/fonc.2022.820696. eCollection 2022. Front Oncol. 2022. PMID: 35756622 Free PMC article.

8

ITM2A as a Tumor Suppressor and Its Correlation With PD-L1 in Breast Cancer.

Zhang R, Xu T, Xia Y, Wang Z, Li X, Chen W. Zhang R, et al. Among authors: xu t. Front Oncol. 2021 Feb 12;10:581733. doi: 10.3389/fonc.2020.581733. eCollection 2020. Front Oncol. 2021. PMID: 33680917 Free PMC article.

9

NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer.

Dong M, Xu T, Cui X, Li H, Li X, Xia W. Dong M, et al. Among authors: xu t. Oncol Lett. 2021 Apr;21(4):323. doi: 10.3892/ol.2021.12585. Epub 2021 Feb 23. Oncol Lett. 2021. PMID: 33692855 Free PMC article.

10

LINC00052 promotes breast cancer cell progression and metastasis by sponging miR-145-5p to modulate TGFBR2 expression.

Dong M, Xu T, Li H, Li X. Dong M, et al. Among authors: xu t. Oncol Lett. 2021 May;21(5):368. doi: 10.3892/ol.2021.12629. Epub 2021 Mar 11. Oncol Lett. 2021. PMID: 33777194 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,415 results

Search Page

Filters